康圣环球品牌怎么样 申请店铺

我要投票 康圣环球在精准医疗行业中的票数:35 更新时间:2024-12-21
康圣环球是哪个国家的品牌?「康圣环球」是康圣环球(北京)医学技术有限公司旗下著名品牌。该品牌发源于北京/海淀区,由创始人黄士昂在2007-11-20期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
康圣环球怎么样

康圣环球医学特检集团(以下简称“康圣环球”)是中国首家和最大高端医学专科特检服务检验集团。康圣环球致力于引领中国专科特检技术和服务的进步,以促进中国专科诊疗和个性化医学的发展和提高。本着病人利益至上、医生需求第一的宗旨,康圣环球遵循国际规范、标准和行业指南,引进和研发世界上最先进的技术和专科特检方法,面向中国大型三级医院、专科医院和综合性医院提供全面、先进和准确的专科特检服务。集团创业和管理团队核心成员均在美国学术和产业界工作十年以上,视野广阔,经验丰富。集团得到了世界上最著名和最大的创投基金凯鹏华盈(KPCB)、晨兴创投、中经合、贝雅等几千万美元的资本支持。并在2011年6月27日,美国梅奥医学中心(MayoClinic)宣布与中国康圣环球医学特检集团正式签署一项长达数年的战略合作协议,梅奥向康圣环球注资,通过其医学检验与病理学部及其旗下的梅奥医学实验室,为康圣环球提供近3000项专业检测技术及实验室质量管理,国际认证标准、信息咨询、标准操作程序(SOPs)和方法学等相关技术,协助康圣环球加速发展其在中国的高品质特检服务,促进中国医学诊断和治疗水平的提高。

康圣环球在北京、上海、武汉已建和在建三万八千平方米具有国际先进水平的、具有国家资质的临床检验、科研合作和应用开发中心,拥有高分辨流式细胞仪、多色流式细胞分选与细胞培养、多色荧光适时幼态细胞扫描成像仪、第二代基因组学测序、基因芯片、全自动DNA/RNA提取、COBAS高灵敏度病毒载量系统、高精度质谱、质谱芯片、高压液相/气相层析、分子细胞、遗传与全自动核型扫描、变性高效色谱分析、分子病理、数字病理、液态芯片、单分子数字免疫、免疫组化、蛋白指纹图谱、激光共聚焦显微镜、电子显微镜等数十个技术平台和专业实验室,向全国三十一个省直辖市,六百多个城市的三千多家医院,尤其是千余家大型三级医院提供三千多项血液、肿瘤、遗传、心脑血管、感染性疾病、自身免疫性疾病等领域和内、外、妇、儿等专科的高精尖诊断检测,并通过与全球顶尖医疗科技机构和大型制药公司合作,向全国广大临床医师提供医学科研、药物试验和转化医学研究服务。


Kangsheng global medical special examination group (hereinafter referred to as "Kangsheng global") is the first and largest high-end medical special examination service inspection group in China. Kangsheng global is committed to leading the progress of special examination technology and services in China, so as to promote the development and improvement of specialized diagnosis and treatment and personalized medicine in China. In line with the tenet of putting patients' interests first and doctors' needs first, Kangsheng universal follows international norms, standards and industry guidelines, introduces and develops the most advanced technology and special examination methods in the world, and provides comprehensive, advanced and accurate special examination services for large-scale tertiary hospitals, specialized hospitals and general hospitals in China. The core members of the group's entrepreneurship and management team have worked in the academic and industrial circles of the United States for more than ten years, with broad vision and rich experience. The group has received capital support of tens of millions of US dollars from KPCB, Chenxing venture capital, China economic cooperation and paya, the world's most famous and largest venture capital fund. And on June 27, 2011, Mayoclinic of the United States announced that it has signed a strategic cooperation agreement with China global medical special inspection group for several years. Mayo has invested in global health. Through its Department of medical testing and pathology and its Mayo Medical Laboratory, it has provided global health with nearly 3000 professional testing technologies and laboratory quality management, international certification standards and information Consulting, SOPs, methodology and other related technologies will help Corson global to accelerate the development of its high-quality special examination services in China and promote the improvement of medical diagnosis and treatment level in China. Kangsheng global has established and is in the process of building 38000 square meters of clinical testing, scientific research cooperation and application development center with international advanced level and national qualification in Beijing, Shanghai and Wuhan. It has high-resolution flow cytometry, multi-color flow cell sorting and cell culture, multi-color fluorescence real-time young cell scanning imager, second-generation genomics sequencing, gene chip, and full-scale fluorescence Automatic DNA / RNA extraction, Cobas high-sensitivity viral load system, high-precision mass spectrometry, mass spectrometry chip, high-pressure liquid / gas chromatography, molecular cell, genetic and full-automatic nuclear scanning, denaturing high-performance chromatography, molecular pathology, digital pathology, liquid chip, single molecule digital immune, immunohistochemistry, protein fingerprint, laser confocal microscope, electron microscope, etc Ten technical platforms and professional laboratories provide more than 3000 hospitals in 31 provinces, municipalities directly under the central government and more than 600 cities in China, especially more than 1000 large tertiary hospitals, with more than 3000 high-end diagnostic tests in the fields of blood, tumor, genetics, cardio cerebrovascular, infectious diseases, autoimmune diseases, and in the fields of internal, external, women, children and other specialties, and have passed the world's top doctors Medical science and technology institutions and large pharmaceutical companies cooperate to provide medical research, drug testing and translational medical research services to clinicians across the country.

本文链接: https://brand.waitui.com/b8bc6d5cc.html 联系电话:18500087003

千城特选小程序码

7×24h 快讯

中工国际:江南环境新建高端环保设备产业化基地奠基

中工国际下属常州江南环境工程有限公司(以下简称“江南环境”)新建高端环保设备产业化基地(简称“新基地”)开工奠基仪式隆重举行。新基地项目是由中工环境科技投资、江南环境建设、中元国际上海院设计、中国中元施工的工业类项目,也是中工国际系统内第一次投资建设装备制造和产业化基地的生动实践。(证券时报)

2小时前

小鹏汽车澳大利亚首家门店开业

36氪获悉,12月21日,小鹏汽车宣布其澳大利亚首家门店开业,现场主要展示了小鹏G6 SUV车型及小鹏飞行汽车。此前,小鹏汽车表示小鹏G6大规模发往澳洲。

2小时前

长安汽车与亿航智能签订飞行汽车合作协议

36氪获悉,12月21日,长安汽车全球科学与艺术中心现场推进暨飞行汽车合作签约活动举行。长安汽车与亿航智能签订了飞行汽车合作协议,双方将对飞行汽车整机等关键技术进行联合攻关,探索研究具有未来感、科技感的产品,布局飞行汽车应用场景,推动商业化进程。

2小时前

天邦食品:与厦门建发及正虹科技签订饲料合作协议

36氪获悉,12月20日,厦门建发、正虹科技及天邦食品就饲料合作举行会谈并签署相关协议。根据合作协议,厦门建发将根据天邦食品的需求,将原料供应给正虹科技,由正虹科技将加工好的饲料供应给天邦食品。未来,正虹与天邦还计划通过天邦下属的“嗨客猪管家”托管业务,共同运营闲置猪场。

2小时前

B站举办第七届国创发布会:持续扶持原创动画,斩获全球近400项大奖

12月21日,哔哩哔哩举办了2024-2025年国创动画作品发布会,公布了43部国创作品。据了解,原创动画依然是B站的重点投入对象,本次B站公布了12部原创动画,占比超过25%。B站扶持动画创作者的专项计划“寻光”也取得了超预期的成绩,计划衍生作品《胶囊计划》系列,目前已入围并收获全球373项专业奖项。2018年至今,B站累计播出国创作品642部,出品原创动画达78部,用户观看时长近6.6亿,互动总数超过2.5亿,用户规模更达到约3.2亿。

2小时前

本页详细列出关于康圣环球的品牌信息,含品牌所属公司介绍,康圣环球所处行业的品牌地位及优势。
咨询